Luciferase Mark Of The Beast

MARK Antibody

34087-100ul 100ul
EUR 302.4

Human IgG antibody Laboratories manufactures the luciferase mark of the beast reagents distributed by Genprice. The Luciferase Mark Of The Beast reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Mark Group: Of The

Anti-MARK Antibody

100ul
EUR 476.4
Description: Rabbit Polyclonal MARK Antibody. Validated in WB and tested in Human, Mouse, Rat.

MARK Conjugated Antibody

100ul
EUR 476.4

Tumors of the head and neck, 102 cases (1.5mm)

1
EUR 300
Description: Head and neck tumor tissue array, 102 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharynx, larynx and salivary glands with grading and TNM staging data

52 kDa Repressor of The Inhibitor of The Protein Kinase (PRKRIR) Antibody

  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

52 kDa Repressor of The Inhibitor of The Protein Kinase (PRKRIR) Antibody

100 ug
EUR 469.2

52 kDa Repressor of The Inhibitor of The Protein Kinase (PRKRIR) Antibody

400 ul
EUR 627.6

52 kDa Repressor of The Inhibitor of The Protein Kinase (PRKRIR) Antibody

80 µl
EUR 343.2

Of The information

Luciferase

HY-P1004 5mg
EUR 555.6

THEMIS 3'UTR Luciferase Stable Cell Line

TU025535 1.0 ml
EUR 2799.6

Themis 3'UTR Luciferase Stable Cell Line

TU120453 1.0 ml Ask for price

THEM4P1 3'UTR Luciferase Stable Cell Line

TU025533 1.0 ml
EUR 2799.6

AAV1 Luciferase

78452 50 µl x 2
EUR 545
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase under the control of a CMV promoter.

AAV2 Luciferase

78453 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 2 (AAV2) is the best characterized AAV serotype. Nearly all recombinant AAV serotypes utilize the AAV2 inverted terminal repeats (ITRs). AAV2 requires the expression of Heparan Sulfate Proteoglycan (HSPG) on the surface of host for cells for binding and internalization. Of nearly all the discovered AAV serotypes, AAV2 has the best transduction efficiency in cell culture and is the best tool for in vitro studies._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase under the control of a CMV promoter.

AAV3 Luciferase

78454 50 µl x 2
EUR 545
Description: Adeno-Associated Virus Serotype 3 (AAV3) shares 82% sequence homology with AAV2, and like AAV2, requires the Heparan Sulfate Proteoglycan (HSPG) receptor for cell attachment. AAV3 vectors transduce human liver cancer cells extremely efficiently because AAV3 utilizes the human Hepatocyte Growth Factor Receptor (hHGFR) as a co-receptor for viral entry, which is highly expressed in these cells. Both the extracellular and intracellular kinase domains of hHGFR are required for AAV3-mediated transgene expression._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV5 Luciferase

78456 50 µl x 2
EUR 545
Description: Adeno-Associated Virus Serotype 5 (AAV5) differs from other parvovirus serotypes according to serological and DNA hybridization data, and AAV5 also uses different inverted terminal repeats (ITRs) compared to other AAV serotypes. AAV5 is the most efficient vector for transducing sensory neurons and is effective at mediating gene transfer into human and murine airway epithelia. In addition, AAV5 vectors show a higher tropism for both mouse and human dendritic cells than AAV1, AAV2, AAV7, or AAV8._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV6 Luciferase

78457 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 6 (AAV6) appears to be related to AAV1 by sequence analysis and shows the best transduction efficiency in pancreatic beta-cells compared to other AAV serotypes. AAV6 vectors are also particularly effective in the transduction of human prostate, breast, and liver cancer cells._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV8 Luciferase

78458 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 8 (AAV8) was isolated from rhesus monkey tissue, and the AAV8 rep and cap nucleotide sequences have 88% homology with AAV7 and 82% with AAV2. AAV8 exhibits greater transduction efficiency in the liver than other AAV serotypes. AAV8 and 9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV9 Luciferase

78459 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications.         _x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

MARS 3'UTR Luciferase Stable Cell Line

TU013031 1.0 ml
EUR 1672.8

Mars 3'UTR Luciferase Stable Cell Line

TU112925 1.0 ml Ask for price

Mars 3'UTR Luciferase Stable Cell Line

TU212891 1.0 ml Ask for price

MARCO 3'UTR Luciferase Stable Cell Line

TU013026 1.0 ml
EUR 1672.8

MARS2 3'UTR Luciferase Stable Cell Line

TU013032 1.0 ml
EUR 1672.8

Marco 3'UTR Luciferase Stable Cell Line

TU112920 1.0 ml Ask for price